Geron Corp. (NASDAQ: GERN) kicked off on Monday, down -0.66% from the previous trading day, before settling in for the closing price of $4.57. Over the past 52 weeks, GERN has traded in a range of $1.64-$5.34.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 46.26%. While this was happening, its average annual earnings per share was recorded -7.93%. With a float of $552.62 million, this company’s outstanding shares have now reached $602.80 million.
The extent of productivity of a business whose workforce counts for 141 workers is very important to gauge.
Geron Corp. (GERN) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Geron Corp. is 8.32%, while institutional ownership is 69.62%. The most recent insider transaction that took place on Jul 08 ’24, was worth 3,073,004. In this transaction EVP, Chief Operating Officer of this company sold 674,348 shares at a rate of $4.56, taking the stock ownership to the 0 shares. Before that another transaction happened on Jun 10 ’24, when Company’s EVP, Chief Medical Officer sold 287,900 for $4.63, making the entire transaction worth $1,334,129. This insider now owns 0 shares in total.
Geron Corp. (GERN) Latest Financial update
#####
According to the Wall Street analysts, stocks earnings will be around -7.93% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 5.00% during the next five years compared to -16.08% drop over the previous five years of trading.
Geron Corp. (NASDAQ: GERN) Trading Performance Indicators
Take a look at Geron Corp.’s (GERN) current performance indicators. Last quarter, stock had a quick ratio of 3.60. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1997.60.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.36, a number that is poised to hit -0.09 in the next quarter and is forecasted to reach -0.12 in one year’s time.
Technical Analysis of Geron Corp. (GERN)
The latest stats from [Geron Corp., GERN] show that its last 5-days average volume of 7.6 million was inferior to 10.8 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 47.61%. Additionally, its Average True Range was 0.23.
During the past 100 days, Geron Corp.’s (GERN) raw stochastic average was set at 62.09%, which indicates a significant increase from 52.09% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 62.03% in the past 14 days, which was higher than the 57.53% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.53, while its 200-day Moving Average is $3.50. Now, the first resistance to watch is $4.63. This is followed by the second major resistance level at $4.72. The third major resistance level sits at $4.79. If the price goes on to break the first support level at $4.47, it is likely to go to the next support level at $4.40. The third support level lies at $4.31 if the price breaches the second support level.
Geron Corp. (NASDAQ: GERN) Key Stats
The company with the Market Capitalisation of 2.74 billion has total of 593,133K Shares Outstanding. Its annual sales at the moment are 240 K in contrast with the sum of -184,130 K annual income. Company’s last quarter sales were recorded 880 K and last quarter income was -67,380 K.
